Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2019 | 1 |
2020 | 1 |
2024 | 0 |
PubMed for id: 223555985
3 results
Results by year
Filters applied: . Clear all
Page 1
The lncRNAs RP1-261G23.7, RP11-69E11.4 and SATB2-AS1 are a novel clinical signature for predicting recurrent osteosarcoma.
Biosci Rep. 2020 Jan 31;40(1):BSR20191251. doi: 10.1042/BSR20191251.
Biosci Rep. 2020.
PMID: 31850493
Free PMC article.
LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2.
Xu M, Xu X, Pan B, Chen X, Lin K, Zeng K, Liu X, Xu T, Sun L, Qin J, He B, Pan Y, Sun H, Wang S.
Xu M, et al.
Mol Cancer. 2019 Sep 6;18(1):135. doi: 10.1186/s12943-019-1063-6.
Mol Cancer. 2019.
PMID: 31492160
Free PMC article.
Item in Clipboard
A novel antisense long non-coding RNA SATB2-AS1 overexpresses in osteosarcoma and increases cell proliferation and growth.
Liu SH, Zhu JW, Xu HH, Zhang GQ, Wang Y, Liu YM, Liang JB, Wang YX, Wu Y, Guo QF.
Liu SH, et al.
Mol Cell Biochem. 2017 Jun;430(1-2):47-56. doi: 10.1007/s11010-017-2953-9. Epub 2017 Feb 11.
Mol Cell Biochem. 2017.
PMID: 28190168
Item in Clipboard
Cite
Cite